Today's Pre-Open MoversAlder BioPharmaceuticals, Inc., (NASDAQ: ALDR) 24.6% LOWER; announced that eptinezumab, its lead product candidate for migraine prevention, met ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Darden Restaurants (DRI) PT Raised to $85 at BofA/Merrill Lynch Following 4Q June 28, 2017 9:15 AM Darden Restaurants (DRI) PT Raised to $94 at Baird Following 4QJune 28, 2017 8:43 AM Darden Restaurants (DRI) PT Raised to $93 at JPMorgan Following 4QJune 28, 2017 8:07 AM Darden Restaurants (DRI) PT Raised to $94 at Deutsche Bank Following 4QJune 28, 2017 7:41 AM Darden Restaurants (DRI) PT Raised to $90 at Jefferies Following 4QJune 28, 2017 7:10 AM